The results of a cohort study show that taking aspirin on a regular basis after receiving a colorectal cancer diagnosis is linked to a decreased risk of both overall and colorectal cancer-specific death, particularly in those with tumors that overexpress cyclooxygenase-2 [59]. This evidence concerns the gene PTGS2 and colorectal cancer.